About Liposomal Amphotericin B injection 50mg
Amphotericin B liposomal injection is used to treat fungal infections such as cryptococcal meningitis (a fungal infection of the lining of the spinal cord and brain) and visceral leishmaniasis (a parasitic disease that usually affects spleen, liver, and bone marrow) in certain people
Precise Reconstitution and AdministrationThis product is strictly for intravenous infusion. Prior to use, reconstitute the lyophilized powder by adding 12 mL of sterile water for injection, yielding a concentration of 4 mg/mL. The resultant solution should be infused slowly over a minimum of 2 hours. This process ensures effective and safe delivery of the medication to target invasive fungal and parasitic infections.
Therapeutic Applications and AdvantagesLiposomal Amphotericin B is recognized for its broad-spectrum action against severe fungal infections and leishmaniasis. The liposomal formulation notably reduces nephrotoxicity compared to conventional amphotericin B, allowing for higher doses and improved tolerability. The product is suitable for both adult and pediatric patients, making it a versatile therapeutic option.
FAQ's of Liposomal Amphotericin B injection 50mg:
Q: How is Liposomal Amphotericin B injection 50mg prepared for administration?
A: To prepare Liposomal Amphotericin B for intravenous infusion, add 12 mL of sterile water for injection to the lyophilized powder, giving a 4 mg/mL solution. After reconstitution, the medication is infused over at least 2 hours.
Q: What medical conditions are treated with this injection?
A: This medication is recommended for treating invasive fungal infections such as aspergillosis, candidiasis, cryptococcosis, and for visceral leishmaniasis, under the guidance of a qualified physician.
Q: When should Liposomal Amphotericin B not be used?
A: It should not be administered to patients with known hypersensitivity to amphotericin B or any of its components.
Q: Where should this product be stored to maintain efficacy?
A: The vials should be stored below 25C and protected from light to ensure potency until the expiry date, which is 24 months from the date of manufacture.
Q: What are the main side effects associated with this medication?
A: While this formulation is less nephrotoxic, potential side effects include nephrotoxicity, infusion-related reactions, and electrolyte disturbances. Patients with preexisting renal issues or imbalances in potassium or magnesium require close monitoring.
Q: What benefits does the liposomal formulation provide over conventional amphotericin B?
A: The liposomal formulation allows for targeted drug delivery and reduces the risk of kidney toxicity, enabling safe administration of higher doses if needed.
Q: How is the dosage of Liposomal Amphotericin B injection determined?
A: Dosage is individualized based on patient weight and clinical indication, commonly ranging from 3 to 5 mg/kg daily, as directed by the attending physician.